Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophins.
| Image |  |
|---|---|
| Description | scientific article published on 11 March 2009 |
| Author/s | |
| Publication date | March 11, 2009 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |